Angela Yellson

Doctor of Medicine,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Career Advice and Mentoring Grant Submission Journal Manuscript Scientific Writing Biostatistics

Areas Of Interest

Leukoedemas, Oral Infusions, Subcutaneous Motor Epilepsy, Focal Eye Segment, Posterior c H ras Proto Oncogenes Organogeneses, Plant Phage T4 Tissue Crossmatchings CD31 Antigens Self Fertilization Ectromelia Education, Nursing, Post-Registration Bartters Disease Capacity, Inspiratory Macrozamia Cybersecurity Hypophosphatemias, Familial Inventory, Hospital Brain Pelizaeus-Merzbacher Sclerosis Carrier Protein, Acyl Deacetylases, Sir2-like Dugbe virus Early B Cell Specific Binding Protein 1 Ritonavir CMP Sialate Pyrophosphorylase Pubic Bone src Family Tyrosine Kinases Hazards, Equipment Implantable Infusion Pump Cholestenone 5 alpha-Reductase Di-tert-butyl-methylphenol Pirenzepine Dihydrochloride Drug Event, Adverse

Professional Narrative

Dr. Angela Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Amgen 2002
Director Medicine, Amgen 2002

Education

Doctor of medicine, Baylor College 2009
Master of Science in physician assistant, Baylor College 1991

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :